Physical and functional interaction between protein kinase C delta and Fyn tyrosine kinase in human platelets

Area of Science:

• Biochemistry
• Molecular Biology
• Hematology

Background:

• Protein kinase C (PKC) isoforms and tyrosine kinases, including Src family kinases, play critical roles in cellular signaling.
• Interactions between PKC and tyrosine kinases are increasingly recognized in various cell types, including platelets.
• The specific interactions and functional consequences of PKCdelta and Fyn kinase in platelet activation remain to be fully elucidated.

Purpose of the Study:

• To investigate the physical and functional interaction between PKCdelta and the Src family kinase Fyn in human platelets.
• To determine the role of this interaction in platelet activation induced by alboaggregin-A.
• To elucidate the signaling pathways involving PKCdelta and Fyn during platelet activation.

Main Methods:

• Human platelets were activated with alboaggregin-A, a snake venom activator of GPIb-V-IX and GPVI receptors.
• Co-immunoprecipitation was used to assess physical interactions between kinases.
• Western blotting with phospho-specific antibodies detected tyrosine and serine phosphorylation.
• Confocal immunofluorescence microscopy visualized kinase translocation.
• Pharmacological inhibitors (bisindolylmaleimide I, PP1, rottlerin) were used to probe kinase activity and signaling pathways.

Main Results:

• PKCdelta and Fyn kinase physically and functionally interact in human platelets activated by alboaggregin-A, involving tyrosine phosphorylation of PKCdelta.
• This interaction is specific, as PKCdelta does not interact with other PKC isoforms (PKCepsilon, lambda) or tyrosine kinases (Syk, Src, Btk).
• Alboaggregin-A stimulation leads to activation and translocation of both Fyn and PKCdelta to the plasma membrane, dependent on Src and PKC kinase activities.
• PKC activity is required for kinase translocation but not for their association.
• PKCdelta inhibition potentiated platelet aggregation, 5-hydroxytryptamine secretion, and calcium response, indicating a negative regulatory role.

Conclusions:

• PKCdelta and Fyn kinase engage in a specific physical and functional interaction during alboaggregin-A-induced platelet activation.
• This interaction is critical for the proper translocation and signaling of these kinases within platelets.
• PKCdelta acts as a negative regulator of key platelet activation processes, including aggregation and secretion.